Actively hiring
Rare Disease Therapeutics
Manufacturing
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Dec 2001 · 24 yr ago
The money's age
Long since its last round
297 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2001 | — | — | handelsregister.de |
Registers and programsofficial lists and records that name the company
| Legal entity | Amgen GmbH | its site |
| Registered | 11 Apr 1989 |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Wir schützen Unternehmen mit effektiven Sicherheitslösungen von Microsoft 365.

Willkommen bei Ultramarin.. Wir bieten eine vielseitige Auswahl an KI-Modellen. Kunden können zwischen Modellen zur Aktienselektion…

Human cells cannot degrade cholesterol, leading to several chronic and orphan diseases. Repair Biotechnologies’ Cholesterol Degrading…

Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.

US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…

Overview. Ambros Therapeutics, headquartered in San Diego, California, is a clinical-stage biotechnology company focused on the development…
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Financials
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2001 | — | Details |





